Global MRD (Minimal Residual Disease) Testing Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Minimal residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. The number of remaining cells may be so small that they do not cause any physical signs or symptoms and often cannot even be detected through traditional methods, such as viewing cells under a microscope and/or by tracking abnormal serum proteins in the blood. An MRD positive test result means that residual (remaining) disease was detected. A negative result means that residual disease was not detected,The most widely used tests to measure MRD are flow cytometry, polymerase chain reaction (PCR) and next-generation sequencing (NGS).
According to our (Global Info Research) latest study, the global MRD (Minimal Residual Disease) Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global MRD (Minimal Residual Disease) Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global MRD (Minimal Residual Disease) Testing market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global MRD (Minimal Residual Disease) Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global MRD (Minimal Residual Disease) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global MRD (Minimal Residual Disease) Testing market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for MRD (Minimal Residual Disease) Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global MRD (Minimal Residual Disease) Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON plc, ArcherDX(Invitae), ARUP Laboratories, Asuragen and Cergentis B.V., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
MRD (Minimal Residual Disease) Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe MRD (Minimal Residual Disease) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of MRD (Minimal Residual Disease) Testing, with price, sales, revenue and global market share of MRD (Minimal Residual Disease) Testing from 2018 to 2023.
Chapter 3, the MRD (Minimal Residual Disease) Testing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MRD (Minimal Residual Disease) Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and MRD (Minimal Residual Disease) Testing market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of MRD (Minimal Residual Disease) Testing.
Chapter 14 and 15, to describe MRD (Minimal Residual Disease) Testing sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global MRD (Minimal Residual Disease) Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global MRD (Minimal Residual Disease) Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global MRD (Minimal Residual Disease) Testing market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global MRD (Minimal Residual Disease) Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global MRD (Minimal Residual Disease) Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global MRD (Minimal Residual Disease) Testing market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for MRD (Minimal Residual Disease) Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global MRD (Minimal Residual Disease) Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON plc, ArcherDX(Invitae), ARUP Laboratories, Asuragen and Cergentis B.V., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
MRD (Minimal Residual Disease) Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Flow Cytometry
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Specialty Clinics and Hospitals
- Diagnostic Laboratories
- Research Institutions
- ICON plc
- ArcherDX(Invitae)
- ARUP Laboratories
- Asuragen
- Cergentis B.V.
- Bio-Rad Laboratories
- Mission Bio
- Guardant Health
- Invivoscribe
- LabCorp
- Inivata
- Natera
- NeoGenomics Laboratories
- Opko Health
- Quest Diagnostics
- Sysmex Corporation
- Adaptive Biotechnologies
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe MRD (Minimal Residual Disease) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of MRD (Minimal Residual Disease) Testing, with price, sales, revenue and global market share of MRD (Minimal Residual Disease) Testing from 2018 to 2023.
Chapter 3, the MRD (Minimal Residual Disease) Testing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MRD (Minimal Residual Disease) Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and MRD (Minimal Residual Disease) Testing market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of MRD (Minimal Residual Disease) Testing.
Chapter 14 and 15, to describe MRD (Minimal Residual Disease) Testing sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of MRD (Minimal Residual Disease) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global MRD (Minimal Residual Disease) Testing Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Flow Cytometry
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Next-Generation Sequencing (NGS)
1.4 Market Analysis by Application
1.4.1 Overview: Global MRD (Minimal Residual Disease) Testing Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Specialty Clinics and Hospitals
1.4.3 Diagnostic Laboratories
1.4.4 Research Institutions
1.5 Global MRD (Minimal Residual Disease) Testing Market Size & Forecast
1.5.1 Global MRD (Minimal Residual Disease) Testing Consumption Value (2018 & 2022 & 2029)
1.5.2 Global MRD (Minimal Residual Disease) Testing Sales Quantity (2018-2029)
1.5.3 Global MRD (Minimal Residual Disease) Testing Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 ICON plc
2.1.1 ICON plc Details
2.1.2 ICON plc Major Business
2.1.3 ICON plc MRD (Minimal Residual Disease) Testing Product and Services
2.1.4 ICON plc MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ICON plc Recent Developments/Updates
2.2 ArcherDX(Invitae)
2.2.1 ArcherDX(Invitae) Details
2.2.2 ArcherDX(Invitae) Major Business
2.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product and Services
2.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ArcherDX(Invitae) Recent Developments/Updates
2.3 ARUP Laboratories
2.3.1 ARUP Laboratories Details
2.3.2 ARUP Laboratories Major Business
2.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ARUP Laboratories Recent Developments/Updates
2.4 Asuragen
2.4.1 Asuragen Details
2.4.2 Asuragen Major Business
2.4.3 Asuragen MRD (Minimal Residual Disease) Testing Product and Services
2.4.4 Asuragen MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Asuragen Recent Developments/Updates
2.5 Cergentis B.V.
2.5.1 Cergentis B.V. Details
2.5.2 Cergentis B.V. Major Business
2.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product and Services
2.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cergentis B.V. Recent Developments/Updates
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-Rad Laboratories Recent Developments/Updates
2.7 Mission Bio
2.7.1 Mission Bio Details
2.7.2 Mission Bio Major Business
2.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Product and Services
2.7.4 Mission Bio MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mission Bio Recent Developments/Updates
2.8 Guardant Health
2.8.1 Guardant Health Details
2.8.2 Guardant Health Major Business
2.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Product and Services
2.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guardant Health Recent Developments/Updates
2.9 Invivoscribe
2.9.1 Invivoscribe Details
2.9.2 Invivoscribe Major Business
2.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Product and Services
2.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Invivoscribe Recent Developments/Updates
2.10 LabCorp
2.10.1 LabCorp Details
2.10.2 LabCorp Major Business
2.10.3 LabCorp MRD (Minimal Residual Disease) Testing Product and Services
2.10.4 LabCorp MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 LabCorp Recent Developments/Updates
2.11 Inivata
2.11.1 Inivata Details
2.11.2 Inivata Major Business
2.11.3 Inivata MRD (Minimal Residual Disease) Testing Product and Services
2.11.4 Inivata MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Inivata Recent Developments/Updates
2.12 Natera
2.12.1 Natera Details
2.12.2 Natera Major Business
2.12.3 Natera MRD (Minimal Residual Disease) Testing Product and Services
2.12.4 Natera MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Natera Recent Developments/Updates
2.13 NeoGenomics Laboratories
2.13.1 NeoGenomics Laboratories Details
2.13.2 NeoGenomics Laboratories Major Business
2.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NeoGenomics Laboratories Recent Developments/Updates
2.14 Opko Health
2.14.1 Opko Health Details
2.14.2 Opko Health Major Business
2.14.3 Opko Health MRD (Minimal Residual Disease) Testing Product and Services
2.14.4 Opko Health MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Opko Health Recent Developments/Updates
2.15 Quest Diagnostics
2.15.1 Quest Diagnostics Details
2.15.2 Quest Diagnostics Major Business
2.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product and Services
2.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Quest Diagnostics Recent Developments/Updates
2.16 Sysmex Corporation
2.16.1 Sysmex Corporation Details
2.16.2 Sysmex Corporation Major Business
2.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product and Services
2.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sysmex Corporation Recent Developments/Updates
2.17 Adaptive Biotechnologies
2.17.1 Adaptive Biotechnologies Details
2.17.2 Adaptive Biotechnologies Major Business
2.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product and Services
2.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Adaptive Biotechnologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MRD (MINIMAL RESIDUAL DISEASE) TESTING BY MANUFACTURER
3.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Manufacturer (2018-2023)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturer (2018-2023)
3.3 Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of MRD (Minimal Residual Disease) Testing by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 MRD (Minimal Residual Disease) Testing Manufacturer Market Share in 2022
3.4.2 Top 6 MRD (Minimal Residual Disease) Testing Manufacturer Market Share in 2022
3.5 MRD (Minimal Residual Disease) Testing Market: Overall Company Footprint Analysis
3.5.1 MRD (Minimal Residual Disease) Testing Market: Region Footprint
3.5.2 MRD (Minimal Residual Disease) Testing Market: Company Product Type Footprint
3.5.3 MRD (Minimal Residual Disease) Testing Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global MRD (Minimal Residual Disease) Testing Market Size by Region
4.1.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2029)
4.1.2 Global MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2029)
4.1.3 Global MRD (Minimal Residual Disease) Testing Average Price by Region (2018-2029)
4.2 North America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.3 Europe MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.4 Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.5 South America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.6 Middle East and Africa MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
5.2 Global MRD (Minimal Residual Disease) Testing Consumption Value by Type (2018-2029)
5.3 Global MRD (Minimal Residual Disease) Testing Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
6.2 Global MRD (Minimal Residual Disease) Testing Consumption Value by Application (2018-2029)
6.3 Global MRD (Minimal Residual Disease) Testing Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
7.2 North America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
7.3 North America MRD (Minimal Residual Disease) Testing Market Size by Country
7.3.1 North America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
7.3.2 North America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
8.2 Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
8.3 Europe MRD (Minimal Residual Disease) Testing Market Size by Country
8.3.1 Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
8.3.2 Europe MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific MRD (Minimal Residual Disease) Testing Market Size by Region
9.3.1 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
10.2 South America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
10.3 South America MRD (Minimal Residual Disease) Testing Market Size by Country
10.3.1 South America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
10.3.2 South America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa MRD (Minimal Residual Disease) Testing Market Size by Country
11.3.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 MRD (Minimal Residual Disease) Testing Market Drivers
12.2 MRD (Minimal Residual Disease) Testing Market Restraints
12.3 MRD (Minimal Residual Disease) Testing Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of MRD (Minimal Residual Disease) Testing and Key Manufacturers
13.2 Manufacturing Costs Percentage of MRD (Minimal Residual Disease) Testing
13.3 MRD (Minimal Residual Disease) Testing Production Process
13.4 MRD (Minimal Residual Disease) Testing Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 MRD (Minimal Residual Disease) Testing Typical Distributors
14.3 MRD (Minimal Residual Disease) Testing Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of MRD (Minimal Residual Disease) Testing
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global MRD (Minimal Residual Disease) Testing Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Flow Cytometry
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Next-Generation Sequencing (NGS)
1.4 Market Analysis by Application
1.4.1 Overview: Global MRD (Minimal Residual Disease) Testing Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Specialty Clinics and Hospitals
1.4.3 Diagnostic Laboratories
1.4.4 Research Institutions
1.5 Global MRD (Minimal Residual Disease) Testing Market Size & Forecast
1.5.1 Global MRD (Minimal Residual Disease) Testing Consumption Value (2018 & 2022 & 2029)
1.5.2 Global MRD (Minimal Residual Disease) Testing Sales Quantity (2018-2029)
1.5.3 Global MRD (Minimal Residual Disease) Testing Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 ICON plc
2.1.1 ICON plc Details
2.1.2 ICON plc Major Business
2.1.3 ICON plc MRD (Minimal Residual Disease) Testing Product and Services
2.1.4 ICON plc MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 ICON plc Recent Developments/Updates
2.2 ArcherDX(Invitae)
2.2.1 ArcherDX(Invitae) Details
2.2.2 ArcherDX(Invitae) Major Business
2.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product and Services
2.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ArcherDX(Invitae) Recent Developments/Updates
2.3 ARUP Laboratories
2.3.1 ARUP Laboratories Details
2.3.2 ARUP Laboratories Major Business
2.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ARUP Laboratories Recent Developments/Updates
2.4 Asuragen
2.4.1 Asuragen Details
2.4.2 Asuragen Major Business
2.4.3 Asuragen MRD (Minimal Residual Disease) Testing Product and Services
2.4.4 Asuragen MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Asuragen Recent Developments/Updates
2.5 Cergentis B.V.
2.5.1 Cergentis B.V. Details
2.5.2 Cergentis B.V. Major Business
2.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product and Services
2.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cergentis B.V. Recent Developments/Updates
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-Rad Laboratories Recent Developments/Updates
2.7 Mission Bio
2.7.1 Mission Bio Details
2.7.2 Mission Bio Major Business
2.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Product and Services
2.7.4 Mission Bio MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mission Bio Recent Developments/Updates
2.8 Guardant Health
2.8.1 Guardant Health Details
2.8.2 Guardant Health Major Business
2.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Product and Services
2.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guardant Health Recent Developments/Updates
2.9 Invivoscribe
2.9.1 Invivoscribe Details
2.9.2 Invivoscribe Major Business
2.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Product and Services
2.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Invivoscribe Recent Developments/Updates
2.10 LabCorp
2.10.1 LabCorp Details
2.10.2 LabCorp Major Business
2.10.3 LabCorp MRD (Minimal Residual Disease) Testing Product and Services
2.10.4 LabCorp MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 LabCorp Recent Developments/Updates
2.11 Inivata
2.11.1 Inivata Details
2.11.2 Inivata Major Business
2.11.3 Inivata MRD (Minimal Residual Disease) Testing Product and Services
2.11.4 Inivata MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Inivata Recent Developments/Updates
2.12 Natera
2.12.1 Natera Details
2.12.2 Natera Major Business
2.12.3 Natera MRD (Minimal Residual Disease) Testing Product and Services
2.12.4 Natera MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Natera Recent Developments/Updates
2.13 NeoGenomics Laboratories
2.13.1 NeoGenomics Laboratories Details
2.13.2 NeoGenomics Laboratories Major Business
2.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product and Services
2.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NeoGenomics Laboratories Recent Developments/Updates
2.14 Opko Health
2.14.1 Opko Health Details
2.14.2 Opko Health Major Business
2.14.3 Opko Health MRD (Minimal Residual Disease) Testing Product and Services
2.14.4 Opko Health MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Opko Health Recent Developments/Updates
2.15 Quest Diagnostics
2.15.1 Quest Diagnostics Details
2.15.2 Quest Diagnostics Major Business
2.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product and Services
2.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Quest Diagnostics Recent Developments/Updates
2.16 Sysmex Corporation
2.16.1 Sysmex Corporation Details
2.16.2 Sysmex Corporation Major Business
2.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product and Services
2.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sysmex Corporation Recent Developments/Updates
2.17 Adaptive Biotechnologies
2.17.1 Adaptive Biotechnologies Details
2.17.2 Adaptive Biotechnologies Major Business
2.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product and Services
2.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Adaptive Biotechnologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MRD (MINIMAL RESIDUAL DISEASE) TESTING BY MANUFACTURER
3.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Manufacturer (2018-2023)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturer (2018-2023)
3.3 Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of MRD (Minimal Residual Disease) Testing by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 MRD (Minimal Residual Disease) Testing Manufacturer Market Share in 2022
3.4.2 Top 6 MRD (Minimal Residual Disease) Testing Manufacturer Market Share in 2022
3.5 MRD (Minimal Residual Disease) Testing Market: Overall Company Footprint Analysis
3.5.1 MRD (Minimal Residual Disease) Testing Market: Region Footprint
3.5.2 MRD (Minimal Residual Disease) Testing Market: Company Product Type Footprint
3.5.3 MRD (Minimal Residual Disease) Testing Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global MRD (Minimal Residual Disease) Testing Market Size by Region
4.1.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2029)
4.1.2 Global MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2029)
4.1.3 Global MRD (Minimal Residual Disease) Testing Average Price by Region (2018-2029)
4.2 North America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.3 Europe MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.4 Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.5 South America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
4.6 Middle East and Africa MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
5.2 Global MRD (Minimal Residual Disease) Testing Consumption Value by Type (2018-2029)
5.3 Global MRD (Minimal Residual Disease) Testing Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
6.2 Global MRD (Minimal Residual Disease) Testing Consumption Value by Application (2018-2029)
6.3 Global MRD (Minimal Residual Disease) Testing Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
7.2 North America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
7.3 North America MRD (Minimal Residual Disease) Testing Market Size by Country
7.3.1 North America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
7.3.2 North America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
8.2 Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
8.3 Europe MRD (Minimal Residual Disease) Testing Market Size by Country
8.3.1 Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
8.3.2 Europe MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific MRD (Minimal Residual Disease) Testing Market Size by Region
9.3.1 Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
10.2 South America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
10.3 South America MRD (Minimal Residual Disease) Testing Market Size by Country
10.3.1 South America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
10.3.2 South America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa MRD (Minimal Residual Disease) Testing Market Size by Country
11.3.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 MRD (Minimal Residual Disease) Testing Market Drivers
12.2 MRD (Minimal Residual Disease) Testing Market Restraints
12.3 MRD (Minimal Residual Disease) Testing Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of MRD (Minimal Residual Disease) Testing and Key Manufacturers
13.2 Manufacturing Costs Percentage of MRD (Minimal Residual Disease) Testing
13.3 MRD (Minimal Residual Disease) Testing Production Process
13.4 MRD (Minimal Residual Disease) Testing Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 MRD (Minimal Residual Disease) Testing Typical Distributors
14.3 MRD (Minimal Residual Disease) Testing Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ICON plc Basic Information, Manufacturing Base and Competitors
Table 4. ICON plc Major Business
Table 5. ICON plc MRD (Minimal Residual Disease) Testing Product and Services
Table 6. ICON plc MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ICON plc Recent Developments/Updates
Table 8. ArcherDX(Invitae) Basic Information, Manufacturing Base and Competitors
Table 9. ArcherDX(Invitae) Major Business
Table 10. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product and Services
Table 11. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. ArcherDX(Invitae) Recent Developments/Updates
Table 13. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. ARUP Laboratories Major Business
Table 15. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 16. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ARUP Laboratories Recent Developments/Updates
Table 18. Asuragen Basic Information, Manufacturing Base and Competitors
Table 19. Asuragen Major Business
Table 20. Asuragen MRD (Minimal Residual Disease) Testing Product and Services
Table 21. Asuragen MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Asuragen Recent Developments/Updates
Table 23. Cergentis B.V. Basic Information, Manufacturing Base and Competitors
Table 24. Cergentis B.V. Major Business
Table 25. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product and Services
Table 26. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cergentis B.V. Recent Developments/Updates
Table 28. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 29. Bio-Rad Laboratories Major Business
Table 30. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 31. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bio-Rad Laboratories Recent Developments/Updates
Table 33. Mission Bio Basic Information, Manufacturing Base and Competitors
Table 34. Mission Bio Major Business
Table 35. Mission Bio MRD (Minimal Residual Disease) Testing Product and Services
Table 36. Mission Bio MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mission Bio Recent Developments/Updates
Table 38. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 39. Guardant Health Major Business
Table 40. Guardant Health MRD (Minimal Residual Disease) Testing Product and Services
Table 41. Guardant Health MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guardant Health Recent Developments/Updates
Table 43. Invivoscribe Basic Information, Manufacturing Base and Competitors
Table 44. Invivoscribe Major Business
Table 45. Invivoscribe MRD (Minimal Residual Disease) Testing Product and Services
Table 46. Invivoscribe MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Invivoscribe Recent Developments/Updates
Table 48. LabCorp Basic Information, Manufacturing Base and Competitors
Table 49. LabCorp Major Business
Table 50. LabCorp MRD (Minimal Residual Disease) Testing Product and Services
Table 51. LabCorp MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. LabCorp Recent Developments/Updates
Table 53. Inivata Basic Information, Manufacturing Base and Competitors
Table 54. Inivata Major Business
Table 55. Inivata MRD (Minimal Residual Disease) Testing Product and Services
Table 56. Inivata MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Inivata Recent Developments/Updates
Table 58. Natera Basic Information, Manufacturing Base and Competitors
Table 59. Natera Major Business
Table 60. Natera MRD (Minimal Residual Disease) Testing Product and Services
Table 61. Natera MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Natera Recent Developments/Updates
Table 63. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. NeoGenomics Laboratories Major Business
Table 65. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 66. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. NeoGenomics Laboratories Recent Developments/Updates
Table 68. Opko Health Basic Information, Manufacturing Base and Competitors
Table 69. Opko Health Major Business
Table 70. Opko Health MRD (Minimal Residual Disease) Testing Product and Services
Table 71. Opko Health MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Opko Health Recent Developments/Updates
Table 73. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 74. Quest Diagnostics Major Business
Table 75. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product and Services
Table 76. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Quest Diagnostics Recent Developments/Updates
Table 78. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 79. Sysmex Corporation Major Business
Table 80. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product and Services
Table 81. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Sysmex Corporation Recent Developments/Updates
Table 83. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. Adaptive Biotechnologies Major Business
Table 85. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product and Services
Table 86. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Adaptive Biotechnologies Recent Developments/Updates
Table 88. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 89. Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in MRD (Minimal Residual Disease) Testing, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and MRD (Minimal Residual Disease) Testing Production Site of Key Manufacturer
Table 93. MRD (Minimal Residual Disease) Testing Market: Company Product Type Footprint
Table 94. MRD (Minimal Residual Disease) Testing Market: Company Product Application Footprint
Table 95. MRD (Minimal Residual Disease) Testing New Market Entrants and Barriers to Market Entry
Table 96. MRD (Minimal Residual Disease) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2023) & (Units)
Table 98. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2024-2029) & (Units)
Table 99. Global MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global MRD (Minimal Residual Disease) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global MRD (Minimal Residual Disease) Testing Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global MRD (Minimal Residual Disease) Testing Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 104. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 105. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global MRD (Minimal Residual Disease) Testing Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global MRD (Minimal Residual Disease) Testing Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 110. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 111. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global MRD (Minimal Residual Disease) Testing Average Price by Application (2018-2023) & (US$/Unit)
Table 114. Global MRD (Minimal Residual Disease) Testing Average Price by Application (2024-2029) & (US$/Unit)
Table 115. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 116. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 117. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 118. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 119. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2023) & (Units)
Table 120. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2024-2029) & (Units)
Table 121. North America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 124. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 125. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 126. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 127. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2023) & (Units)
Table 128. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2024-2029) & (Units)
Table 129. Europe MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe MRD (Minimal Residual Disease) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 132. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 133. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 134. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 135. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2023) & (Units)
Table 136. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2024-2029) & (Units)
Table 137. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 140. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 141. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 142. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 143. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2023) & (Units)
Table 144. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2024-2029) & (Units)
Table 145. South America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 148. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 149. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 150. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 151. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2023) & (Units)
Table 152. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2024-2029) & (Units)
Table 153. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 155. MRD (Minimal Residual Disease) Testing Raw Material
Table 156. Key Manufacturers of MRD (Minimal Residual Disease) Testing Raw Materials
Table 157. MRD (Minimal Residual Disease) Testing Typical Distributors
Table 158. MRD (Minimal Residual Disease) Testing Typical Customers
Table 1. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. ICON plc Basic Information, Manufacturing Base and Competitors
Table 4. ICON plc Major Business
Table 5. ICON plc MRD (Minimal Residual Disease) Testing Product and Services
Table 6. ICON plc MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. ICON plc Recent Developments/Updates
Table 8. ArcherDX(Invitae) Basic Information, Manufacturing Base and Competitors
Table 9. ArcherDX(Invitae) Major Business
Table 10. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product and Services
Table 11. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. ArcherDX(Invitae) Recent Developments/Updates
Table 13. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. ARUP Laboratories Major Business
Table 15. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 16. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ARUP Laboratories Recent Developments/Updates
Table 18. Asuragen Basic Information, Manufacturing Base and Competitors
Table 19. Asuragen Major Business
Table 20. Asuragen MRD (Minimal Residual Disease) Testing Product and Services
Table 21. Asuragen MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Asuragen Recent Developments/Updates
Table 23. Cergentis B.V. Basic Information, Manufacturing Base and Competitors
Table 24. Cergentis B.V. Major Business
Table 25. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product and Services
Table 26. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cergentis B.V. Recent Developments/Updates
Table 28. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 29. Bio-Rad Laboratories Major Business
Table 30. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 31. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bio-Rad Laboratories Recent Developments/Updates
Table 33. Mission Bio Basic Information, Manufacturing Base and Competitors
Table 34. Mission Bio Major Business
Table 35. Mission Bio MRD (Minimal Residual Disease) Testing Product and Services
Table 36. Mission Bio MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mission Bio Recent Developments/Updates
Table 38. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 39. Guardant Health Major Business
Table 40. Guardant Health MRD (Minimal Residual Disease) Testing Product and Services
Table 41. Guardant Health MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guardant Health Recent Developments/Updates
Table 43. Invivoscribe Basic Information, Manufacturing Base and Competitors
Table 44. Invivoscribe Major Business
Table 45. Invivoscribe MRD (Minimal Residual Disease) Testing Product and Services
Table 46. Invivoscribe MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Invivoscribe Recent Developments/Updates
Table 48. LabCorp Basic Information, Manufacturing Base and Competitors
Table 49. LabCorp Major Business
Table 50. LabCorp MRD (Minimal Residual Disease) Testing Product and Services
Table 51. LabCorp MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. LabCorp Recent Developments/Updates
Table 53. Inivata Basic Information, Manufacturing Base and Competitors
Table 54. Inivata Major Business
Table 55. Inivata MRD (Minimal Residual Disease) Testing Product and Services
Table 56. Inivata MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Inivata Recent Developments/Updates
Table 58. Natera Basic Information, Manufacturing Base and Competitors
Table 59. Natera Major Business
Table 60. Natera MRD (Minimal Residual Disease) Testing Product and Services
Table 61. Natera MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Natera Recent Developments/Updates
Table 63. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. NeoGenomics Laboratories Major Business
Table 65. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product and Services
Table 66. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. NeoGenomics Laboratories Recent Developments/Updates
Table 68. Opko Health Basic Information, Manufacturing Base and Competitors
Table 69. Opko Health Major Business
Table 70. Opko Health MRD (Minimal Residual Disease) Testing Product and Services
Table 71. Opko Health MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Opko Health Recent Developments/Updates
Table 73. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 74. Quest Diagnostics Major Business
Table 75. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product and Services
Table 76. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Quest Diagnostics Recent Developments/Updates
Table 78. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 79. Sysmex Corporation Major Business
Table 80. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product and Services
Table 81. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Sysmex Corporation Recent Developments/Updates
Table 83. Adaptive Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. Adaptive Biotechnologies Major Business
Table 85. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product and Services
Table 86. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Adaptive Biotechnologies Recent Developments/Updates
Table 88. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 89. Global MRD (Minimal Residual Disease) Testing Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in MRD (Minimal Residual Disease) Testing, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and MRD (Minimal Residual Disease) Testing Production Site of Key Manufacturer
Table 93. MRD (Minimal Residual Disease) Testing Market: Company Product Type Footprint
Table 94. MRD (Minimal Residual Disease) Testing Market: Company Product Application Footprint
Table 95. MRD (Minimal Residual Disease) Testing New Market Entrants and Barriers to Market Entry
Table 96. MRD (Minimal Residual Disease) Testing Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2023) & (Units)
Table 98. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2024-2029) & (Units)
Table 99. Global MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global MRD (Minimal Residual Disease) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global MRD (Minimal Residual Disease) Testing Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global MRD (Minimal Residual Disease) Testing Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 104. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 105. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global MRD (Minimal Residual Disease) Testing Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global MRD (Minimal Residual Disease) Testing Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 110. Global MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 111. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global MRD (Minimal Residual Disease) Testing Average Price by Application (2018-2023) & (US$/Unit)
Table 114. Global MRD (Minimal Residual Disease) Testing Average Price by Application (2024-2029) & (US$/Unit)
Table 115. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 116. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 117. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 118. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 119. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2023) & (Units)
Table 120. North America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2024-2029) & (Units)
Table 121. North America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 124. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 125. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 126. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 127. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2023) & (Units)
Table 128. Europe MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2024-2029) & (Units)
Table 129. Europe MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe MRD (Minimal Residual Disease) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 132. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 133. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 134. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 135. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2023) & (Units)
Table 136. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2024-2029) & (Units)
Table 137. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 140. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 141. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 142. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 143. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2018-2023) & (Units)
Table 144. South America MRD (Minimal Residual Disease) Testing Sales Quantity by Country (2024-2029) & (Units)
Table 145. South America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America MRD (Minimal Residual Disease) Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2018-2023) & (Units)
Table 148. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Type (2024-2029) & (Units)
Table 149. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2018-2023) & (Units)
Table 150. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Application (2024-2029) & (Units)
Table 151. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2018-2023) & (Units)
Table 152. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity by Region (2024-2029) & (Units)
Table 153. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 155. MRD (Minimal Residual Disease) Testing Raw Material
Table 156. Key Manufacturers of MRD (Minimal Residual Disease) Testing Raw Materials
Table 157. MRD (Minimal Residual Disease) Testing Typical Distributors
Table 158. MRD (Minimal Residual Disease) Testing Typical Customers
LIST OF FIGURES
Figure 1. MRD (Minimal Residual Disease) Testing Picture
Figure 2. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Type in 2022
Figure 4. Flow Cytometry Examples
Figure 5. Polymerase Chain Reaction (PCR) Examples
Figure 6. Next-Generation Sequencing (NGS) Examples
Figure 7. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Application in 2022
Figure 9. Specialty Clinics and Hospitals Examples
Figure 10. Diagnostic Laboratories Examples
Figure 11. Research Institutions Examples
Figure 12. Global MRD (Minimal Residual Disease) Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global MRD (Minimal Residual Disease) Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global MRD (Minimal Residual Disease) Testing Sales Quantity (2018-2029) & (Units)
Figure 15. Global MRD (Minimal Residual Disease) Testing Average Price (2018-2029) & (US$/Unit)
Figure 16. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of MRD (Minimal Residual Disease) Testing by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 MRD (Minimal Residual Disease) Testing Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 MRD (Minimal Residual Disease) Testing Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Region (2018-2029)
Figure 23. North America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 26. South America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 28. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. Global MRD (Minimal Residual Disease) Testing Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Application (2018-2029)
Figure 33. Global MRD (Minimal Residual Disease) Testing Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. United States MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Region (2018-2029)
Figure 54. China MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. MRD (Minimal Residual Disease) Testing Market Drivers
Figure 75. MRD (Minimal Residual Disease) Testing Market Restraints
Figure 76. MRD (Minimal Residual Disease) Testing Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of MRD (Minimal Residual Disease) Testing in 2022
Figure 79. Manufacturing Process Analysis of MRD (Minimal Residual Disease) Testing
Figure 80. MRD (Minimal Residual Disease) Testing Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. MRD (Minimal Residual Disease) Testing Picture
Figure 2. Global MRD (Minimal Residual Disease) Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Type in 2022
Figure 4. Flow Cytometry Examples
Figure 5. Polymerase Chain Reaction (PCR) Examples
Figure 6. Next-Generation Sequencing (NGS) Examples
Figure 7. Global MRD (Minimal Residual Disease) Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Application in 2022
Figure 9. Specialty Clinics and Hospitals Examples
Figure 10. Diagnostic Laboratories Examples
Figure 11. Research Institutions Examples
Figure 12. Global MRD (Minimal Residual Disease) Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global MRD (Minimal Residual Disease) Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global MRD (Minimal Residual Disease) Testing Sales Quantity (2018-2029) & (Units)
Figure 15. Global MRD (Minimal Residual Disease) Testing Average Price (2018-2029) & (US$/Unit)
Figure 16. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of MRD (Minimal Residual Disease) Testing by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 MRD (Minimal Residual Disease) Testing Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 MRD (Minimal Residual Disease) Testing Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Region (2018-2029)
Figure 23. North America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 26. South America MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value (2018-2029) & (USD Million)
Figure 28. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. Global MRD (Minimal Residual Disease) Testing Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Application (2018-2029)
Figure 33. Global MRD (Minimal Residual Disease) Testing Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. United States MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Region (2018-2029)
Figure 54. China MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa MRD (Minimal Residual Disease) Testing Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa MRD (Minimal Residual Disease) Testing Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. MRD (Minimal Residual Disease) Testing Market Drivers
Figure 75. MRD (Minimal Residual Disease) Testing Market Restraints
Figure 76. MRD (Minimal Residual Disease) Testing Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of MRD (Minimal Residual Disease) Testing in 2022
Figure 79. Manufacturing Process Analysis of MRD (Minimal Residual Disease) Testing
Figure 80. MRD (Minimal Residual Disease) Testing Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
